Prospective multicenter phase II clinical trial of FOLFIRI chemotherapy as a neoadjuvant treatment for colorectal cancer with multiple liver metastases

Ji-Yeon KIM; Jin-Soo KIM; Moo-Jun BAEK; Chang-Nam KIM; Won-Jun CHOI; Dong-Kook PARK; Hwan NAMGUNG; Sang-Chul LEE; Sang-Jeon LEE.
Journal of the Korean Surgical Society ; : 154-160, 2013.
Artículo en Inglés | WPRIM | ID: wpr-56690

Documentos relacionados

  1. Office Records Management Practices of a Leading Tertiary Care Institute in India.
  2. Exploring treatment outcomes in Stage II-III rectal cancer patients undergoing neoadjuvant therapy at a tertiary care center in Pakistan: a comprehensive analysis of pathological outcomes.
  3. Emerging role of multimodality treatment in gall bladder cancer: Outcomes following 510 consecutive resections in a tertiary referral center.
  4. Assessment of gastric-acid suppressants prescribing at an internal medicine service of a tertiary hospital in Latin America: A retrospective record review study.
  5. Are high-cost drug funding mechanisms fit for purpose? A retrospective study of individual funding requests in an NHS tertiary hospital.
  6. Improved survival after implementation of ultra-radical surgery in advanced epithelial ovarian cancer: Results from a tertiary referral center.
  7. [Modified FOLFIRINOX for advanced pancreatic cancer: a tertiary center experience from China].
  8. Clinical and Etiological Profile of Pancytopenia in Tertiary Hospital.
  9. [The Tertiary Hospital's Medical Materials Supply in the Prevention of Public Health Emergencies].
  10. Contamination assessment of orthodontic bands after different pre-cleaning methods at a tertiary care hospital.